Screener
Revolution Medicines, Inc. RVMD Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Revolution Medicines, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-208969
FAQ
- What is Revolution Medicines, Inc.'s return on equity?
- Revolution Medicines, Inc. (RVMD) reported return on equity of -76.7% in Q1 2026.
- How has Revolution Medicines, Inc.'s return on equity changed year-over-year?
- Revolution Medicines, Inc.'s return on equity decreased by 109.1% year-over-year, from -36.7% to -76.7%.
- What is the long-term trend for Revolution Medicines, Inc.'s return on equity?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s return on equity has grown at a 13.7% compound annual growth rate (CAGR), from -34.7% to -58.1%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Revolution Medicines, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude